J&J Vax Shows Promising Signs of Protecting Against Delta Variant
New Jersey | July 2, 2021
Johnson & Johnson’s Covid-19 vaccine showed promising signs in a small laboratory study of protecting against the Delta variant spreading across the U.S. and other countries. In laboratory testing, the vaccine triggered a strong immune response in blood samples taken from eight vaccinated people, J&J said Thursday. The positive performance adds to a growing set of evidence indicating currently authorized Covid-19 vaccines can safeguard against the Delta variant, which appears to be more contagious than earlier strains.
(Excerpts from the Wall Street Journal)